key: cord-0708659-d43pn1s8 authors: Meng, Detao; Jin, Zhaohui; Chen, Keke; Yu, Xin; Wang, Yixuan; Du, Wenjun; Wei, Jingran; Xi, Jianing; Fang, Boyan title: Quality of life predicts rehabilitation prognosis in Parkinson's disease patients: Factors influence rehabilitation prognosis date: 2022-04-16 journal: Brain Behav DOI: 10.1002/brb3.2579 sha: 28a633c279561f82b36feb9f41023e247a9398be doc_id: 708659 cord_uid: d43pn1s8 BACKGROUND: Rehabilitation has been reported to improve the quality of life (QoL) of patients with Parkinson's disease (PD). Nevertheless, not all patients are satisfied with rehabilitation outcomes and could achieve a significant improvement in QoL. OBJECTIVE: To detect possible predictors of QoL improvement in patients with PD after rehabilitation. METHODS: A total of 86 PD patients were included and followed up for 3 months with a 39‐item Parkinson's Disease Questionnaire summary index (PDQ‐39 SI) as the primary endpoint. All patients received 2 weeks of multidisciplinary intensive rehabilitation treatment (MIRT). Changes in patients' QoL were assessed using the PDQ‐39 at baseline and at the 3‐month follow‐up. The reliable change index (RCI) was adapted to determine the individual QoL outcome. The predictors of QoL outcome were detected using logistic regression analysis. RESULTS: After a 3‐month follow‐up, PDQ‐39 SI decreased significantly from 22.95 ± 9.75 to 18.73 ± 10.32 (P < 0.001). Scores for QoL improved (RCI>10.9) after rehabilitation for 18.6% of the patients, and 74.4% of patients reported an unchanged QoL (−10.9≤RCI≤10.9), while 7.0% of patients reported a worsening of QoL (RCI<−10.9). Among the baseline parameters, the PDQ‐39 SI was a baseline predictor for changes in QoL in the logistic regression model (OR: 1.15, CI: 1.07–1.24, P < 0.001). CONCLUSIONS: MIRT could improve QoL for some patients with PD, and PDQ‐39 score at baseline is the most important predictor for QoL improvements after rehabilitation for this patients. Parkinson's disease (PD) is a progressive neurodegenerative disease that is characterized by motor symptoms such as bradykinesia, resting tremor, rigidity, and a sequence of nonmotor symptoms, such as cognitive decline, anxiety, and depression (Bloem et al., 2021) . It can lead to a decline in quality of life (QoL) very early and deteriorates as the disease progresses (Carod-Artal et al., 2007) , even under the best medical treatment or with deep brain stimulation . Therefore, rehabilitation therapies are considered an adjuvant to pharmacological and surgical treatments to maximize functional abilities and to minimize secondary complications (Armstrong & Okun, 2020) . Meanwhile, rehabilitation has also been reported to improve the QoL related to PD (Clarke et al., 2016; Ferrazzoli et al., 2018; Monticone et al., 2015; Morris et al., 2009; Rodrigues De Paula et al., 2006; Tickle-Degnen et al., 2010) , but not all studies yield the same results (Wade et al., 2003) . Although several reasons could explain the lack of benefit, such as previously satisfactory management leaving little room for improvement, lack of psychological intervention, etc. (Playford, 2003) . Therefore, this revealed that not all patients are satisfied with the rehabilitation results and can achieve a significant improvement in QoL. The reasons may be multidimensional, but strategies to identify which patient could benefit from rehabilitation seem to be important for optimized treatment outcomes. For instance, we can adopt different rehabilitation strategies for patients with different outcomes to reduce the waste of medical resources and improve the therapeutic effect of individual patients. On the other hand, for those who may benefit less, other treatment methods should be actively adopted to improve the patient's QoL as much as possible. Therefore, we performed this study to understand the effects of multidisciplinary intensive rehabilitation treatment (MIRT) for mild to moderate PD patients. In particular, the relative contributions of motor and nonmotor baseline parameters to the rehabilitation outcome on QoL were analyzed. We attempted to detect the possible predictors of QoL improvement for PD patients after rehabilitation with a 3-month follow-up. In this ongoing, prospective single-center cohort study (multidisciplinary rehabilitation registration study on PD, registration number: ChiCTR2000033768), a total of 86 PD patients attending our inpatient rehabilitation project in Beijing Rehabilitation Hospital from June 2020 to July 2021 were included and followed up for 3 months. All patients received 2 weeks of MIRT. None of the patients underwent drug adjustment from training to 3 months of follow-up. Inclusion criteria were: (1) idiopathic PD as confirmed by a neurologist using the Movement Disorder Society criteria (Postuma et al., 2015) ; (2) no deep brain stimulation or in vivo implantation treatment; (3) were able to understand each item of the informed consent and willing to sign the informed consent. The exclusion criteria were as follows: (1) atypical parkinsonism, such (Hoehn & Yahr, 1967) , and MDS-UPDRS score (Goetz et al., 2007) . The evaluation of the H&Y stage and MDS-UPDRS score were carried out under the medication ON stage. MIRT is specifically designed for rehabilitation for PD patients and is constituted with a multidisciplinary, aerobic, motor-cognitive, intensive, and goal-based rehabilitation treatment (Ferrazzoli et al., 2018; Frazzitta et al., 2012; Frazzitta et al., 2015) . All patients received a 2 weeks of MIRT. The 2-week program comprised four sessions. The first session is one-on-one physical therapy by a physical ther- QoL was assessed by the Chinese version of the Parkinson's Disease Questionnaire (PDQ-39) (Neff et al., 2018) . The PDQ-39 is a validated disease-specific HRQoL measure in PD (Neff et al., 2018) Jacobson & Truax, 1991) . A PDQ-39 score decrease of more than 10.9 points was termed "improved," and a score increase of more than 10.9 points was termed "worsen"; changes between −10.9 and 10.9 were termed "unchanged" ( Witt et al., 2011) . Both the "worsen" and "unchanged" groups were assigned to the "nonimproved" group. Cognitive Assessment (MoCA) (Nasreddine et al., 2005) , depression was evaluated by the Geriatric Depression Scale (GDS) (Montorio & Izal, 1996) , fatigue was evaluated by the Parkinson Fatigue Scale (PFS•16) (Brown et al., 2005) , and apathy was evaluated by the Modified Apathy Evaluation Scale (MAES) (Starkstein et al., 1992) at baseline as a factor that affects QoL according to the literature (D'Iorio et al., 2017; Tang et al., 2020 ). Data distribution and normality were evaluated with the Shapiro-Wilk test. Normally distributed data are expressed as the mean ± standard deviation (SD), while nonnormally distributed data are reported as the median (interquartile range). The PDQ-39 SI and subgroup score at baseline and with follow-up for 3 months were compared by the paired sample t test. Spearman correlations or Pearson correlations were used to explore the relationship between changes in QoL scores and demographic and clinical parameters, including age, age at diagnosis, disease duration, LEDD, H&Y stage, MDS-UPDRS score, GDS, MAES, PFS-16, and PDQ-39 SI score at baseline. Spearman's correlation was also used to evaluate changed nonmotor parameters, including GDS, MAES, and PFS-16 scores, associated with changes in QoL. Furthermore, demographic and clinical parameters at baseline were compared between the "improved" and "nonimproved" groups according to the PDQ-39 RCI using univariate analysis. Demographic and clinical parameters at baseline as revealed by the first-step analyses (less strictly selected: P < 0.10, one-tailed) were included in a logistic regression analysis as independent variables with the dichotomous variable improved/nonimproved in terms of the PDQ-39 RCI as the dependent variable. P values < 0.05 (two-tailed) were regarded as significant. Receiver operating characteristic (ROC) analyses were used to evaluate the predictive utility of logistic regression models on patients' QoL improvement (Schrag et al., 2017) . These statistical data were analyzed using SPSS version 21 (SPSS Inc., Chicago, IL). Of 155 patients screened, 86 patients (36 males) were included in the final analysis (see Figure 1 ). The mean age at baseline was 60.24 years (SD = 7.82), and the median disease duration was 6.00 years (interquartile range = 4.00). The patient baseline characteristics are shown in Table 1 . (P < 0.001). Bodily discomfort, social support, and activities of daily living showed no significant changes. In the "improved" group, the bod-ily discomfort (P = 0.029), cognition (P = 0.002), stigma (P = 0.002), emotional wellbeing (P < 0.001), activity of daily living (P = 0.002), and mobility (P < 0.001) domains decreased significantly. There is a downward trend in the social support and communication domain. In the "nonimproved" group, the mobility domain decreased significantly (P < 0.001); however, there was no significant change or increase in other domains. The PDQ-39 subgroup analysis was shown in Figure 3 . PDQ-39 SI at baseline was significantly associated with changes in the PDQ-39 SI after a 3-month follow-up (r = 0.422, P<0.001). Meanwhile, the changes in the PDQ-39 SI were significantly associated with GDS score changes (r = 0.537, P < 0.001) and MAES score changes (r = 0.284, P < 0.01) after a 3-month follow-up. The correlation analysis results are shown in Appendix 1. The effects of MIRT for mild to moderate PD patients in the PDQ-39 subgroup. The comparison of PDQ-39 subgroup scores for all patients, the unimproved group, and the improved group at baseline and after rehabilitation is separately shown on the left of the dotted line, between the two dotted lines, and on the right of the dotted line. The cognition, stigma, emotional wellbeing, and mobility domains decreased significantly, and the communication domain increased significantly. In the "improved" group, bodily discomfort, cognition, stigma, emotional wellbeing, activities of daily living, and mobility domains decreased significantly. In the "nonimproved" group, the mobility domain decreased significantly, and there was no change or increase significantly in other domains (T, total; NI, nonimproved; I, improved. *P < 0.05, **P < 0.01, ***P < 0.001). MIRT, multi-disciplinary intensive rehabilitation treatment showed that the same is not true for all PD patients. QoL improved steadily in only a fraction of patients with a relatively conservative index to define the change in QoL after rehabilitation . Therefore, we developed a model that could be used to predict improvement in QoL after rehabilitation in PD patients. We found that impaired QoL was the most important predictor of benefit in mild to moderate PD after rehabilitation in our prognostic model. Furthermore, we found that changes in the PDQ-39 SI were significantly associated with PDQ-39 SI at baseline and were significantly associated with GDS score changes and MAES score changes. increasing (Clarke et al., 2016; Ferrazzoli et al., 2018; Monticone et al., 2015; Morris et al., 2009; Rodrigues De Paula et al., 2006) . Ferrazzoli et al.'s study (Ferrazzoli et al., 2018) suggested that MIRT, which consisted of a multidisciplinary, aerobic, intensive, and motor-cognitive rehabilitation treatment, could improve QoL in patients with PD that could last for 3 months (Ferrazzoli et al., 2018) . Monticone et al.'s study (Monticone et al., 2015) found that PD patients could obtain a benefit from multidisciplinary rehabilitative care for at least 1 year after the intervention. Multidisciplinary rehabilitative care could change the course of motor impairment, balance, activities of daily living, and QoL. Morris et al.'s study (Morris et al., 2009) suggested that inpatient rehabilitation produces short-term reductions in disability and improve-ments in QoL in people with PD for at least 3 months. As mentioned above (Ferrazzoli et al., 2018; Monticone et al., 2015; Morris et al., 2009 ), our finding also suggest that the improvement of QoL was considered to be significant by MIRT in mild to moderate PD patients. QoL scores significantly improved for 18.6% of the patients with a more conservative method . Another study showed that QoL improved in only 7% of patients who received the best medical treatment with the same definition of improvement et al., 2008) . Rehabilitation therapy could improve the motor and nonmotor symptoms of PD (Lamotte et al., 2015; Rafferty et al., 2017) , and consistent with previous reports (Rafferty et al., 2017) , patients with advanced PD could obtain more benefit than those with mild PD from rehabilitation therapy. There are some limitations to this study that must be acknowledged. First, an important limitation of our findings is the selected patient population. We collected only mild to moderate PD patients, which might lead to selection bias. PD patients in the H&Y:4-5 stage could not complete MIRT due to their serious condition, and they may need to adopt other rehabilitation strategies, so we did not include those patients. Second, due to the COVID-19 outbreak, patients were unable to get to the hospital for a detailed kinematic evaluation, such as UPDRS-III score and UPRDS part IV score, at the 3-month follow-up, which could reflect the improvement of the patient's motor function and motor complications (Goetz et al., 2007) . Last, our follow-up time was only 3 months. Although there is evidence that PD patients can benefit from rehabilitation treatments, it is unclear how long the benefits could last (Abbruzzese et al., 2016) . A long-term observation still is needed. In conclusion, the present study shows that MIRT could improve the QoL of PD patients, especially mild to moderate PD patients with impaired QoL. Impaired QoL at baseline could predict the benefit of rehabilitation for PD patients. Patients with impaired QoL should actively participate in rehabilitation exercises to improve their QoL. Further research is needed in more PD patients. Rehabilitation for Parkinson's disease: Current outlook and future challenges Diagnosis and Treatment of Parkinson Disease Insights into the mechanisms of deep brain stimulation Parkinson's disease. The Lancet The Parkinson fatigue scale Determinants of quality of life in Brazilian patients with Parkinson's disease Efficacy of short-term multidisciplinary intensive rehabilitation in patients with different Parkinson's disease motor subtypes: A prospective pilot study with 3-month follow-up Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Movement Disorders Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: A randomised controlled study Predicting quality of life outcomes after subthalamic nucleus deep brain stimulation Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: A randomized controlled trial with 1-year follow-up Intensive rehabilitation treatment in early Parkinson's disease: A randomized pilot study with a 2-year follow-up Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders Parkinsonism: onset, progression, and mortality Clinical significance: A statistical approach to defining meaningful change in psychotherapy research Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: A review Predictors to quality of life improvements after subthalamic stimulation in Parkinson's disease What is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial The geriatric depression scale: A review of its development and utility A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment Using the PDQ-39 in routine care for Parkinson's disease Back to the basics: Regular exercise matters in parkinson's disease: Results from the National Parkinson Foundation QII registry study Multidisciplinary rehabilitation for people with Parkinson's disease MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders Regular exercise, quality of life, and mobility in parkinson's disease: A longitudinal analysis of national parkinson foundation quality improvement initiative data Quality of life in Parkinson's disease: The relative importance of the symptoms. Movement Disorders Quality of life in Parkinson's disease: The relative importance of the symptoms. Movement Disorders Improvement in quality of life following a multidisciplinary rehabilitation program for patients with Parkinson's disease Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson's disease Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: A cohort study Quality of life predicts outcome of deep brain stimulation in early Parkinson disease Reliability, validity, and clinical correlates of apathy in Parkinson's disease Cognitive function and quality of life in parkinson's disease: A cross-sectional study Self-management rehabilitation and health-related quality of life in Parkinson's disease: A randomized controlled trial Multidisciplinary rehabilitation for people with Parkinson's disease: A randomised controlled study Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease Quality of life predicts rehabilitation prognosis in Parkinson's disease patients We are grateful to all the patients and the medical staff of the Neurological Rehabilitation Center of Beijing Rehabilitation Hospital who contributed to this project. The authors declare no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. The peer review history for this article is available at https://publons. com/publon/10.1002/brb3.2579 ORCID Boyan Fang https://orcid.org/0000-0002-9935-433X